Having higher vs. lower levels of vitamin A was linked to better measures of FEV1 and forced vital capacity in children and ...

Toby Maher, MD, PhD, professor of clinical medicine, Keck Medicine of USC, discusses the impact of changes in lung function in patients with idiopathic pulmonary fibrosis (IPF). How does the rate of ...

Nintedanib offered no significant advantage over placebo in patients with interstitial lung disease (ILD) following a severe SARS-CoV-2 infection. No significant differences were observed between ...

Nasdaq provides after market quotes of stock trades from 4:00 P.M. EST to 8:00 P.M. EST. After Hours participation from Market Makers and ECNs is strictly voluntary. Investors who anticipate trading ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Oral nerandomilast doses of 9 mg and 18 mg were ...

TETON-1 data show inhaled treprostinil improves FVC and reduces worsening in IPF, supporting a potential new treatment and combo strategy. In this Q&A, Nathan dissects the study’s findings and the ...

SAN FRANCISCO — The investigational oral agent nerandomilast was superior to placebo at slowing the decline in forced vital capacity (FVC) among patients with progressive pulmonary fibrosis (PF), ...